ETON PHARMACEUTICALS INC. - COMMON STOCK

Eton Pharmaceuticals to Present at Piper Sandler 37th Annual Healthcare Conference on December 4th

24 Nov 2025 16:30:00 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th

12 Nov 2025 16:30:00 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Third Quarter 2025 Financial Results

06 Nov 2025 16:05:04 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025

23 Oct 2025 16:30:00 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals to Participate at 2025 Wells Fargo Healthcare Conference

20 Aug 2025 06:50:00 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Second Quarter 2025 Financial Results

07 Aug 2025 16:05:02 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025

28 Jul 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution)

08 Jul 2025 06:50:00 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Addition to Russell 2000® and Russell 3000® Indexes

27 Jun 2025 06:50:00 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution

28 May 2025 17:28:00 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals to Participate at Upcoming Investor Conferences

14 May 2025 16:30:00 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports First Quarter 2025 Financial Results

13 May 2025 16:01:00 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025

01 May 2025 16:30:00 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)

28 Apr 2025 06:50:00 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals Out-Licenses International Rights to Increlex®

01 Apr 2025 07:00:00 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results

18 Mar 2025 06:50:00 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600

14 Mar 2025 06:50:00 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025

04 Mar 2025 06:50:00 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules

03 Mar 2025 06:50:00 بحسب Nasdaq GlobeNewswire

Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600

07 Feb 2025 06:50:00 بحسب Nasdaq GlobeNewswire